Our previously published results showed that inhibition of NF-κB by its potent inhibitor, parthenolide, diminished symptoms of neuropathy, potentiated morphine analgesia, and diminished pronociceptive markers of microglial cell polarization (IL-1β, IL-18, and iNOS) [25, 37]. Here, NFKB1 is linked to neuropathy.